ALT
Altimmune, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website altimmune.com
- Employees(FY) 52
- ISIN US02155H2004
Performance
+3.76%
1W
+6.52%
1M
-8.56%
3M
+239.41%
6M
-28.8%
YTD
+74.13%
1Y
Profile
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Investment Analysis Report: ALT
Overview
ALT is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $470.66 million. In this report, we will conduct a detailed analysis of ALT's financial health, earnings and revenue growth, profitability, operating margin, o...
Technical Analysis of ALT 2024-05-10
Overview:
In analyzing the technical indicators for ALT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
-
...
Recent News & Updates
- 2024-05-16 18:15
- 2024-05-14 17:45
- 2024-05-14 00:47
- 2024-05-11 09:47
- 2024-05-10 03:58
- 2024-05-09 07:00
- 2024-05-08 23:57
ALT Stock Earnings: Altimmune Beats EPS for Q1 2024(Investorplace)
- 2024-05-08 19:00
- 2024-05-07 20:50
- 2024-05-07 07:30
- 2024-05-06 19:30
- 2024-05-02 07:30
- 2024-05-01 19:30
- 2024-05-01 07:30
Altimmune to Participate at Two Upcoming Conferences(GlobeNewswire)
- 2024-04-30 19:30
Altimmune to Participate at Two Upcoming Conferences(Globenewswire)
- 2024-04-25 17:24
Altimmune Statement on the Passing of Dr. Stephen Harrison(GlobeNewswire)
- 2024-04-25 05:24
Altimmune Statement on the Passing of Dr. Stephen Harrison(Globenewswire)
- 2024-03-29 00:00
- 2024-03-27 22:49
- 2024-03-27 07:00
- 2024-03-27 06:29
- 2024-03-26 23:53
ALT Stock Earnings: Altimmune Beats EPS for Q4 2023(Investorplace)
- 2024-03-26 19:58
- 2024-03-26 19:00
- 2024-03-20 07:30
- 2024-03-19 19:30
- 2024-02-25 20:26
Why Is Altimmune (ALT) Stock Up 14% Today?(Investorplace)
- 2024-02-19 21:26
- 2024-02-13 02:07
- 2024-01-02 18:30
Page 1 of 5
previousnext